(Q73544184)
Statements
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study (English)
D H Mahoney
J J Shuster
R Nitschke
S Lauer
C P Steuber